Cascadian Therapeutics Inc (USA) Share Price

Stocks

04/01/18	Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	GL
02/01/18	Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	GL
13/12/17	Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	GL
07/12/17	Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	GL
08/11/17	Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CASCADIAN THERAPEUTICS INC (USA)	-.--%	+0.50%	-	-	0
ARGENX SE	-0.10%	+0.10%	+74.33%	+133.26%	57.73B
WUXI APPTEC CO., LTD.	-3.80%	-6.24%	+67.04%	+86.36%	54.69B
INSMED INCORPORATED	+1.17%	+5.83%	+16.39%	+468.18%	24.18B
BIONTECH SE	+0.38%	+1.33%	-14.32%	-11.76%	23.75B
WUXI BIOLOGICS (CAYMAN) INC.	-0.87%	+5.14%	+45.23%	-3.76%	19.82B
GENMAB A/S	+3.78%	+5.65%	+44.99%	-26.23%	17.14B
PHARMAESSENTIA CORPORATION	+3.46%	+17.72%	+206.66%	+364.07%	16.75B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-7.35%	+9.17%	+35.13%	-	15.57B
EXELIXIS, INC.	+2.79%	+4.91%	+29.26%	+195.60%	13.96B
Average	-0.08%	+5.15%	+56.08%	+150.71%	27.06B
Weighted average by Cap.	-0.62%	+2.51%	+57.88%	+139.29%

Employees

Sector